Male breast cancer; Analysis of 58 cases in Shiraz, south of Iran

Breast Disease

Volumn 31, Issue 1, 2010, Pages 29-32

  Tahmasebi, Sedigheh ^a   Akrami, Majid ^a   Omidvari, Shapoor ^a   Salehi, Alireza ^a   Talei, Abdolrasoul ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast; Cancer; epidemiology; Male gender; pathology

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; FAMILY HISTORY; HISTOPATHOLOGY; HUMAN; INCIDENCE; INTRADUCTAL CARCINOMA; IRAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALE BREAST; MASTECTOMY; MEDICAL RECORD; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; HUMANS; IRAN; MALE; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 78751483911     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/BD-2009-0293     Document Type: Article

References (27)

1. W.L.Donegan, P.N. Redlich, P.J. Lang et al., Carcinoma of the breast in males: a multiinstitutional survey, Cancer 83 (1998), 498-509.
2. B. Salvadori, R. Saccozzi, A. Manzari et al., Prognosis of breast cancer in males: an analysis of 170 cases, Eur J Cancer 30A (1994), 930-935.
3. S.H. Giordano, D.S. Cohen, A.U. Buzdar et al., Breast carcinoma in men: a populationbased study, Cancer 101(1) (1 Jul 2004), 51-57.
4. Surveillance, Epidemiology, and End Results (SEER) Program. Publicuse data (1993-1997). Bethesda (MD): National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2000.
5. R.K. Matsuno, W.F. Anderson, S. Yamamoto, H. Tsukuma, R.M. Pfeiffer, K. Kobayashi et al., Earlyand lateonset breast cancer types among women in the United States and Japan, Cancer Epidemiol Biomarkers Prev 16 (2007), 1437-1442.
6. T.D. Hill, H.J. Khamis, J.E. Tyczynski and H.J. Berkel, Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival, Ann Epidemiol 15 (2005), 773-780.
7. J. Cho, W. Han, E. Ko, J.W. Lee, S.Y. Jung, E.K. Kim et al., The clinical and histopathological characteristics of male breast cancer patients [In Korean], J Breast Cancer 10 (2007), 211-216.
8. M.A. Sharif, N. Mamoon, A. Arif, S. Mushtaq and M.T. Khadim, Histological and immunohistochemical study of male breast carcinoma in Northern Pakistan, J PakMed Assoc 59(2) (Feb 2009), 67-71.
9. A.J. Sasco, A.B. Lowenfels and P. Paskerde Jong, Review article: epidemiology of male breast cancer. A metaanalysis of published casecontrol studies and discussion of selected aetiological factors, Int J Cancer 53 (1993), 538-549.
10. A. Ioka, H. Tsukuma, W. Ajiki and A. Oshima, Survival of male breast cancer patients: a populationbased study in Osaka, Japan, Jpn J Clin Oncol 36 (2006), 699-703.
11. I.S. Fentiman, A. Fourquet and G.N. Hortobagyi, Male breast cancer, Lancet 367 (2006), 595-604.
12. A. Agrawal, A.A. Ayantunde, R. Rampaul and J.F. Robertson, Male breast cancer: a review of clinical management, Breast Cancer Res Treat 103 (2007), 11-21. (Pubitemid 46653271)
13. C.E. ScottConner, P.R. Jochimsen, H.R. Menck and D.J. Winchester, An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients, Surgery 126 (1999), 775-780.
14. S. Tahmasebi, A.R. Talei, A. Talei and A. Fazelzadeh, Age of onset in female breast cancer; a single center study, Middle East Journal of Cancer, in process.
15. P.E. Goss, C. Reid, M. Pintilie et al.,Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996, Cancer 85(3) (1999), 629-639.
16. R.E. Tarone and K.C. Chu, The greater impact of menopause on ER than ER+ breast cancer incidence: a possible explanation, Cancer Causes Control 13(1) (2002), 7-14.
17. B. Cutuli, C.C. Le Nir, D. Serin et al., Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases, Crit Rev Oncol Hematol 11 (2009), [Epub ahead of print].
18. A. Goldhirsch, W.C. Wood, R.D. Gelber et al., Progress and promise: highlightsof the international expert consensus on the primary therapy of early breast cancer 2007, Ann Oncol 18(7) (2007), 1133-1144.
19. E. Yildirim and U. Berberoglu, Male breast cancer: a 22 ye ar experience, Eur J Surg Oncol 24(6) (1998), 548-552.
20. C.S. Bagley, M.N. Wesley, R.C. Young et al., Adjuvant chemotherapy in males with cancer of the breast, Am J Clin Oncol 10(1) (1987), 55-60.
21. J.M.Walshe,A.W.Berman,U.Vatas et al., Aprospective study of adjuvant CMF in male with node positive breast cancer 20 year follow up, Breast Cancer Res Treat 103(2) (2007), 177-183.
22. A. Chakravarthy and C.R. Kim, Post mastectomy radiation in male breast cancer, Radiother Oncol 65(2) (2002), 99-103.
23. A. Yoney, A. Kucuk and M. Unsal, Male breast cancer: a retrospective analysis, Cancer Radiother 13(2) (2009), 103-107.
24. L. Ottini, D. Palli, S. Rizzoc et al., Male breast cancer, Crit Rev Oncol Hematol 6 (2009), [Epub ahead of print].
25. R.E. Tarone and K.C. Chu, The greater impact of menopause on ER than ER+ breast cancer incidence: a possible explanation (United States), Cancer Causes Control 13(1) (2002), 7-14.
26. D. Muir, R. Kanthan and S.C. Kanthan, Male versus female breast cancers: a population based comparative immunohistochemical analysis, Arch Pathol Lab Med 127(1) (2003), 36-41.
27. E. Avisar, E. McParland, D. Dicostanzo et al., Prognostic factors in node negativemale breast cancer, ClinBreastCancer 7(4) (2006), 331-335.